Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Our main goal in neuroscience is advancing the understanding of the human nervous system and the mechanisms behind its disorders. However, many invasive ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...